Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7672
Reference
MSAN(2022)01
Name
Paroxetine (Seroxat®) 20mg/10ml oral suspension
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Paroxetine (Seroxat®) 20mg/10ml oral suspension will be discontinued in July 2022.
2. There are limited supplies remaining.
3. Paroxetine tablets and unlicensed specials of paroxetine 10mg/5ml oral suspension remain available and can support an uplift in demand.
2. There are limited supplies remaining.
3. Paroxetine tablets and unlicensed specials of paroxetine 10mg/5ml oral suspension remain available and can support an uplift in demand.
Contact Name
Contact Email
Contact Address
Scottish Government<br> St Andrew’s House<br> Regent Road<br> Edinburgh EH1 3DG.
Created
2022-07-19 00:00:00
Click to go back to homepage